Change search criteria ↓

Search results

28 projects found matching your search criteria:

  1. 1. Evaluation of the efficiency of Spindle Assembly Checkpoint during mouse oocyte meiosis

    Principal investigator: dr hab. Zbigniew Piotr Polański

    Uniwersytet Jagielloński, Wydział Biologii i Nauk o Ziemi

    Call: OPUS 1, Panel: NZ3

  2. 2. Strategy to overcome the "ionic checkpoint" and improve the antitumor immunotherapy.

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny

    Call: OPUS 29, Panel: NZ7

  3. 3. Multiparameter analysis of co-inhibitory and co-stimulatory immune checkpoints and their role in the induction of immuno…

    Principal investigator: dr Dorota Suszczyk

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 22, Panel: NZ6

  4. 4. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

    Call: SONATA 18, Panel: NZ7

  5. 5. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 22, Panel: NZ7

  6. 6. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ6

  7. 7. The immune checkpoints in non-small cell lung cancer - research on genetic and epigenetic mechanism regulating mRNA and …

    Principal investigator: dr hab. Monika Jasek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 17, Panel: NZ5

  8. 8. Structural and functional analysis of immune checkpoints

    Principal investigator: prof. Grzegorz Dubin

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: OPUS 13, Panel: NZ1

  9. 9. The role of arginase-1 in antitumor efficacy of cancer immunotherapy using checkpoint inhibitors

    Principal investigator: prof. Dominika Anna Nowis

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 12, Panel: NZ6

  10. 10. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  11. 11. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors…

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: ST5

  12. 12. Heterogeneity immunocompetent cells during chimeric antigen receptor T cell (CAR-T) CD19 immunotherapy.

    Principal investigator: Aleksandra Maria Oszer

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ6

  13. 13. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu…

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

    Call: OPUS 24, Panel: NZ5

  14. 14. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne…

    Principal investigator: Katarzyna Joanna Dziubek

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: PRELUDIUM 21, Panel: NZ1

  15. 15. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  16. 16. Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 pro…

    Principal investigator: dr Łukasz Dariusz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA BIS 11, Panel: NZ7

  17. 17. Novel factors involved in cell cycle control after DNA damage.

    Principal investigator: dr Michał Zbigniew Malewicz

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

    Call: OPUS 21, Panel: NZ1

  18. 18. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Principal investigator: Magdalena Maria Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 20, Panel: ST4

  19. 19. The clinical significance of immunosuppression in ovarian cancer microenvironments

    Principal investigator: dr Anna Maria Pawłowska-Łachut

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 20, Panel: NZ6

  20. 20. Single cell multi-omics in defining how specific oncogenic alterations shape the immune microenvironment and responses t…

    Principal investigator: prof. Bożena Kamińska-Kaczmarek

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 20, Panel: NZ4

  21. 21. Development of a three-dimensional in vitro model for studying the mechanisms of immunostimulatory activity of PD-1/PD-L…

    Principal investigator: Justyna Natalia Kocik-Król

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  22. 22. Inhibitors of BTLA-HVEM complex formation as potential targets for cancer immunotheraphy

    Principal investigator: dr Marta Marcelina Spodzieja

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 13, Panel: ST5

  23. 23. Guardian of a cell cycle: role of HO-1 in HSC proliferation

    Principal investigator: Monika Żukowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 13, Panel: NZ1

  24. 24. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 12, Panel: NZ6

  25. 25. Genotoxicity of antitumor compound 3-bromopyruvate in the yeast Saccharomyces cerevisiae.

    Principal investigator: dr Magdalena Cal

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: SONATA 9, Panel: NZ2

  26. 26. Identification of Saccharomyces cerevisiae genes maintaining cell diploidy and genome stability

    Principal investigator: dr hab. Adrianna Martyna Skoneczna

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 2, Panel: NZ2

  27. 27. MAP kinase signaling pathway in response to replication stress and DNA damage in root meristem cells of Vicia faba

    Principal investigator: Konrad Szczepan Winnicki

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska; Katedra Cytofizjologii

    Call: PRELUDIUM 1, Panel: NZ3

  28. 28. Genotoxicity of arsenic in the yeast Saccharomyces cerevisiae

    Principal investigator: dr Ireneusz Bernard Litwin

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: PRELUDIUM 1, Panel: NZ2

Graphic design and implementation: Jakub Piotrowski